BIOTHERANOSTICS, INC.
14Patents
13Active
14Granted
46Portfolio score
Filing activity: Dec 2, 2003 → Nov 18, 2022 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7504214B2 | Predicting outcome with tamoxifen in breast cancer | Chemistry; Metallurgy | 87 | Expired |
| US7930105B2 | Grading of breast cancer | Chemistry; Metallurgy | 6 | Active |
| US9447470B2 | Tumor grading and cancer prognosis | Chemistry; Metallurgy | 6 | Active |
| US9670553B2 | Determining tumor origin | Chemistry; Metallurgy | 2 | Active |
| US10329624B2 | Grading of breast cancer | Chemistry; Metallurgy | 1 | Active |
| US10538816B2 | Identification of tumors | Physics | 1 | Active |
| US9856533B2 | Predicting breast cancer treatment outcome | Chemistry; Metallurgy | 1 | Active |
| US11078538B2 | Post-treatment breast cancer prognosis | Chemistry; Metallurgy | 0 | Active |
| US12215390B2 | Integration of tumor characteristics with breast cancer index | Chemistry; Metallurgy | 0 | Active |
| US11549148B2 | Neuroendocrine tumors | Chemistry; Metallurgy | 0 | Active |
| US11530448B2 | Integration of tumor characteristics with breast cancer index | Chemistry; Metallurgy | 0 | Active |
| US11021754B2 | Tumor grading and cancer prognosis | Chemistry; Metallurgy | 0 | Active |
| US10253369B2 | Predicting likelihood of response to combination therapy | Chemistry; Metallurgy | 0 | Active |
| US11430544B2 | Identification of tumors and tissues | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.